57P VIVA trial: Randomized comparison of adjuvant regorafenib plus durvalumab versus observation in stage IV colorectal cancer with no evidence of disease
A. Pastorino, S. Lonardi, C. Cremolini, J. Giuliani et autres
it (code pays fourni par la source)